Statistics for An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition
Total visits
views | |
---|---|
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition | 272 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
jciinsight-2-92111.pdf | 269 |
java.util.UUID:d06fc5ad-406c-4054-9363-eb3a05f47006 | 50 |
java.util.UUID:84225296-e44a-404d-8d2b-5270f0b69550 | 18 |
java.util.UUID:bc145f72-0a92-4fac-a9dd-ce5dddf91d50 | 8 |
Top country views
views | |
---|---|
United States | 209 |
Germany | 9 |
Ukraine | 7 |
Russia | 4 |
Canada | 3 |
Australia | 2 |
France | 2 |
United Kingdom | 2 |
Italy | 2 |
Sweden | 2 |
China | 1 |
Malaysia | 1 |
Poland | 1 |
Top city views
views | |
---|---|
Wilmington | 56 |
Fairfield | 33 |
Ann Arbor | 22 |
Cambridge | 14 |
Houston | 13 |
Kiez | 8 |
Jacksonville | 7 |
Kiev | 7 |
Lake Mary | 5 |
San Francisco | 4 |
Baltimore | 3 |
Saint Petersburg | 3 |
Brisbane | 2 |
Brooklyn | 2 |
Chicago | 2 |
Grùmolo | 2 |
Paris | 2 |
Seattle | 2 |
Toronto | 2 |
Washington | 2 |
Bristol | 1 |
Gunzenhausen | 1 |
Indianapolis | 1 |
Katowice | 1 |
Malmö | 1 |
Moscow | 1 |
Ottawa | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seremban | 1 |
Stockholm | 1 |